Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000820081-14-000003)

Filing Details

Accession Number:: 0000820081-14-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-02-18 15:59:14
Reporting Period:: 2014-02-13

Filing Date:: 2014-02-18
Accepted Time:: 2014-02-18 15:59:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
820081	Cambrex Corp	CBM	Pharmaceutical Preparations (2834)	222476135

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1192621	M Steven Klosk	One Meadowlands Plaza East Rutherford NJ 07073	President & Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-02-13	10,000	$13.75	155,870	No	4	M	Direct
Common Stock	Disposition	2014-02-13	10,000	$19.75	145,870	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2014-02-13	10,000	$0.00	10,000	$13.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2014-07-26	No	4	M	Direct

Footnotes

The option, representing a right to purchase a total of 10,000 shares, became exercisable in four equal annual installments beginning on July 26, 2008, which was the first anniversary of the date on which the option was granted.
Corrects a mathematical error.